Targeting cell growth in BRCA1 cancer
Breast cancer is the second most common cancer in Australian women. We propose that breast cancers associated with the inherited breast cancer gene BRCA1 display unique cellular and molecular features that we can use to develop new and highly specific treatments. We will determine if BRCA1 cancers are especially sensitive to drugs that target a molecule CDK2 when used alone or in combination with other cancer therapies.
Associate Professor Grant McArthur
Cancer Council Research Grant
Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre
Award / Duration
Research Grant: 2005-2007